首页|期刊导航|中国神经再生研究（英文版）|Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches

Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches

Francois Grand'Maison Michael Yeung Sarah A. Morrow Liesly Lee Francois Emond Brian J. Ward Pierre Laneuville Robyn Schecter

中国神经再生研究（英文版）2018，Vol.13Issue(11)：1871-1874,4.

中国神经再生研究（英文版）2018，Vol.13Issue(11)：1871-1874,4.DOI:10.4103/1673-5374.239432

Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches

Francois Grand'Maison ¹Michael Yeung ²Sarah A. Morrow ³Liesly Lee ⁴Francois Emond ⁵Brian J. Ward ⁶Pierre Laneuville ⁷Robyn Schecter⁸

作者信息

1. Neuro Rive-Sud, H?pital Charles LeMoyne, Greenfield Park, Quebec, Canada
2. Clinical Neurosciences, Foothills Medical Centre, Calgary, Alberta, Canada
3. London Health Sciences Center (LHSC), Western University, London, Ontario, Canada
4. Department of Neurology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
5. Centre Hospitalier Universitaire de Québec - h?pital de l'Enfant-Jésus, Quebec City, Quebec, Canada
6. Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
7. Department of Medicine, McGill University, Montreal, Quebec, Canada
8. Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, Canada
折叠

摘要

关键词

relapsing multiple sclerosis/high efficacy disease-modifying therapies/treatment optimization/treatment sequencing/therapeutic inertia/sub-optimal treatment/progressive disease/immune effects

Key words

引用本文复制引用

Francois Grand'Maison,Michael Yeung,Sarah A. Morrow,Liesly Lee,Francois Emond,Brian J. Ward,Pierre Laneuville,Robyn Schecter..Sequencing of high-efficacy disease-modifying therapies in multiple sclerosis: perspectives and approaches[J].中国神经再生研究（英文版）,2018,13(11):1871-1874,4.

基金项目

This manuscript was funded by Novartis Pharmaceuticals Canada Inc. （）

中国神经再生研究（英文版）

OACSCDCSTPCD

ISSN：1673-5374

访问量1

下载量0

段落导航